Atlas Trials

The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World Study

Clinical trial NCT05453448 · COMPLETED

Trial details

NCT number
NCT05453448
Sponsor
Xiangya Hospital of Central South University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Antiviral Drugs
Start date
2022-05-01
Primary completion
2022-05-30
Enrollment
272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.